Scanning NSE · BSE · NYSE · NASDAQ

BridgeBio Oncology Therapeutics, Inc. - (BBOT) share price

BridgeBio Oncology Therapeutics, Inc. - (NASDAQ:BBOT) last traded at $2.04, down 5.99% on the day (quote 2026-11-06 21:00 UTC), with a market cap of $0.16B and a 52-week range of $1.98 to $14.87.

Key facts for BridgeBio Oncology Therapeutics, Inc. -
ExchangeNASDAQ
CurrencyUSD
Last price$2.04
1-day move-5.99%
52-week range$1.98 - $14.87
Market cap$0.16B
From 52-week high-86.30%
Volume vs average1.2x
Falling Shares risk score56/100 (HIGH)
CountryUnited States

Frequently asked questions

Why is BridgeBio Oncology Therapeutics, Inc. - falling today?

BridgeBio Oncology Therapeutics, Inc. - (NASDAQ:BBOT) is down 5.99% at its latest quote and trades 86.3% below its 52-week high. A price fall alone does not identify a cause: Falling Shares Intelligence links a move to a filing, order or news item only when a source supports it.

What is the BridgeBio Oncology Therapeutics, Inc. - share price today?

BridgeBio Oncology Therapeutics, Inc. - (NASDAQ:BBOT) last traded at $2.04, a -5.99% move on the day as of 2026-11-06 21:00 UTC. Market data comes from public feeds and may be delayed; it is not investment advice.

What is the 52-week range of BridgeBio Oncology Therapeutics, Inc. -?

BridgeBio Oncology Therapeutics, Inc. -'s 52-week low is $1.98 and its 52-week high is $14.87; the shares trade 86.3% below the high.

What is the market cap of BridgeBio Oncology Therapeutics, Inc. -?

BridgeBio Oncology Therapeutics, Inc. - has a market capitalisation of about $0.16B at the latest price.

What are the risks of investing in BridgeBio Oncology Therapeutics, Inc. -?

Falling Shares Intelligence rates BridgeBio Oncology Therapeutics, Inc. - 56/100 (HIGH) on price stress, volume and disclosure signals. Risk scores are analytical indicators, not allegations or investment advice. Review exchange filings and the company's own disclosures before any decision.

Data is compiled from public exchange feeds and may be delayed. Not investment advice.

Wung Thomas, Editor-in-Chief: wungthomas@fallingshares.com. General enquiries and corrections: info@fallingshares.com